Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease
Clinical trial NCT05465317 · COMPLETED
Trial details
- NCT number
- NCT05465317
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-08
- Primary completion
- 2023-05-02
- Enrollment
- 62197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.